Skip to content

New comprehensive treatment to improve the therapeutic effect of advanced tongue squamous cell carcinoma

oral and maxillofacial surgery (Tumors of Oral and Maxillo-facial Region)

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-08000386
Enrollment
Unknown
Registered
2008-12-17
Start date
2008-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant tumors of Oral and Maxillo-facial Region Tongue squamous cell carcinoma

Interventions

Group A:1.Thermo-chemotherapy
2.Surgical
3.Thermal radiation method.
Group B:1. Surgical techniques
2. Chemotherapy
3. Radiotherapy.

Sponsors

Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: first visit patients who diagnosed as advanced squamous cell carcinoma of tongue and the partial resection of the tumor is feasible. There is no metastasis when checked by the chest X-rays, liver and gallbladder renal ultrasonography B and whole body bone emission computed tomography.

Exclusion criteria

Exclusion criteria: Exclusion criteria: Patient with advanced squamous cell carcinoma of tongue whose general condition is too poor to tolerate hyperthermia, chemotherapy, radiotherapy or surgery in patients with advanced treatment. Blood biochemistry, electrocardiogram, liver and kidney function tests are used to determine the patient's general condition. poor general condition includes HB 133umol/L.

Design outcomes

Primary

MeasureTime frame
distant metastases;local recurrence;survival rate;

Secondary

MeasureTime frame
Re-treatment rate;Disease-free survival;Disease Exist Survival;

Countries

China

Contacts

Public ContactHongzhang Huang
huanghongzhang@tom.com+86 020 83862531;83862531

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026